These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2773510)

  • 1. Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Jul; 19(7):743-54. PubMed ID: 2773510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Aug; 19(8):815-22. PubMed ID: 2815824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA
    Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.
    Ko RJ; Sattler FR; Nichols S; Akriviadis E; Runyon B; Appleman M; Cohen JL; Koda RT
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1376-80. PubMed ID: 1929296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma.
    Hakim L; Bourne DW; Triggs EJ
    J Chromatogr; 1988 Jan; 424(1):111-7. PubMed ID: 3366822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gender on the disposition of cefotaxime and desacetylcefotaxime.
    Guay DR; Matzke GR; Heim KL; Halstenson CE; Abraham PA; Keane WF
    Ther Drug Monit; 1987 Sep; 9(3):259-62. PubMed ID: 3672567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.
    Guerra Valero YC; Dorofaeff T; Roberts JA; Lipman J; Coulthard MG; Sparkes L; Wallis SC; Parker SL
    Anal Bioanal Chem; 2021 Jul; 413(17):4483-4491. PubMed ID: 34041575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function.
    Ings RM; Fillastre JP; Godin M; Leroy A; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S379-91. PubMed ID: 6294787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of fever on cefotaxime pharmacokinetics].
    Demotes-Mainard F; Albin H; Ragnaud JM; Gin H; Vincon G; Aubertin J
    Pathol Biol (Paris); 1988 Feb; 36(2):155-8. PubMed ID: 3279384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cefotaxime and desacetylcefotaxime in cerebrospinal fluid by solid-phase extraction and high-performance liquid chromatography.
    Bafeltowska JJ; Buszman E; Mandat K; Hawranek J
    J Chromatogr A; 2002 Nov; 976(1-2):249-54. PubMed ID: 12462616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assay of cefotaxime and desacetylcefotaxime in plasma and urine by high performance liquid chromatography].
    Demotes-Mainard F; Vinçon G; Bouchet JL; Jarry C; Albin H
    Ann Biol Clin (Paris); 1984; 42(4):301-5. PubMed ID: 6093635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of cefotaxime and desacetylcefotaxime in human plasma and cerebrospinal fluid by high-performance liquid chromatography.
    Scanes T; Hundt AF; Swart KJ; Hundt HK
    J Chromatogr B Biomed Sci Appl; 2001 Jan; 750(1):171-6. PubMed ID: 11204218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography.
    Dell D; Chamberlain J; Coppin F
    J Chromatogr; 1981 Dec; 226(2):431-40. PubMed ID: 6274890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.